Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Nostrand Robert L. Van currently holds 82,900 shares of Intra-Cellular Therapies, Inc. (ITCI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Nostrand Robert L. Van has been a net seller of ITCI stock. They have purchased $26.4K and sold $5.3M worth of shares.
Nostrand Robert L. Van's most recent insider trade was on Jan 7, 2026, when they sold 50,000 shares at $0.00 per share.
Nostrand Robert L. Van serves as Executive at Intra-Cellular Therapies, Inc. (ITCI). They have executed 80 insider transactions totaling $5.3M over their tenure at the company.
Nostrand Robert L. Van holds the position of Executive at Intra-Cellular Therapies, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 13 years and currently hold a stake valued at $0.
Nostrand Robert L. Van has shown a selling trading pattern, with $26.4K in total purchases and $5.3M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Nostrand Robert L. Van was on Aug 11, 2022, when they sold $1.6M worth of ITCI shares. This transaction involved 28,500 shares at $57.15 per share.
Nostrand Robert L. Van currently owns 82,900 shares of Intra-Cellular Therapies, Inc. (ITCI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Nostrand Robert L. Van's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Nostrand Robert L. Van has 80 Form 4 filings on record as an insider at Intra-Cellular Therapies, Inc..
Set alerts for Nostrand Robert L. Van and 40,000+ other insiders.